To assess how a patient with pulmonary arterial hypertension (PAH) is faring on therapy, look at the right heart, said Anjali ...

Autologous mononuclear cells showed substantial activity in patients with advanced heart failure — and even though the study ...

The total costs to care for adult patients with heart failure will increase to $142 billion annually by 2050, according to a scientific statement published April 16 by the American Heart Association ...

"If we take the totality of evidence from this new trial, which is in line with the previous studies, and take all of the data together in a meta-analysis, it confirms what we have in the current ...

A major new study shows that giving heart attack patients a cholesterol-lowering combo treatment early on – not months later ...

Researchers have found in a new study that in patients with heart failure and iron deficiency, ferric carboxymaltose did not ...

The Heart Failure Drugs Market is poised for a transformative decade between 2025 and 2035. As heart failure continues to ...

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all, new research suggests.

The trial is assessing the therapy for individuals with ischemic heart failure of minimised ejection fraction.